-
-
-
One of the real buzzes at Novembers annual scientific sessions of the American Heart Association (AHA; Dallas, Texas) was the continuing clinical validation of the role of public access defibrillation in reducing mortality. Clinical studies showing the effectiveness of automated external defibrillators (AEDs) presented at the AHA conference were excellent news for virtually every major defibrillator company.
-
Abbott Laboratories (Abbott Park, Illinois) unveiled a collaboration and license agreement with global pharmaceutical company Wyeth (Madison, New Jersey) to develop an automated blood test to monitor therapeutic levels of the anti-rejection drug Rapamune.
-
CardioGenesis (Foothill Ranch, California) reported that Chairman and Chief Executive Officer Michael Quinn has resumed the position of president, replacing Darrell Eckstein, who left the company to pursue other interests.
-
-
Recognition of Washington states Medicaid disease management program as Best Disease Management Program Medicaid by the Disease Management Association of America is helping focus attention on the value of such programs for controlling costs and improving health care in Medicaid.
-
According to the Washington State Department of Social and Health Services in Olympia, studies have shown clearly that a relatively small number of beneficiaries with certain chronic illnesses account for a disproportionate share of Medicaid services.
-
Medicaid plan would restrict nursing homes to truly poor; Nebraska unveils mental health plan
-
